Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

33.24 -0.66 (-1.93%)
Streaming Delayed Price Updated: 3:21 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,613,449
Open 33.94
Bid (Size) 33.24 (37)
Ask (Size) 33.25 (27)
Prev. Close 33.90
Today's Range 33.01 - 34.08
52wk Range 31.77 - 54.93
Shares Outstanding 5,606,688,356
Dividend Yield 4.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated. 
Via Benzinga
Taylor Swift Boosts Travis Kelce's Popularity: Stocks That Could Benefit From The Love Story
NFL star Travis Kelce's romance with musician Taylor Swift could be a win for brand partners in terms of endorsements and deals. 
Via Benzinga

Performance

YTD
-35.14%
-35.14%
1 Month
-6.03%
-6.03%
3 Month
-8.82%
-8.82%
6 Month
-18.72%
-18.72%
1 Year
-24.68%
-24.68%

More News

Read More
2 High-Yield Dividend Stocks to Buy in October
Via The Motley Fool
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
Via Investor's Business Daily
Pfizer's Diversity Program Faces Legal Heat, Advocacy Group Revives Discrimination Case
Via Benzinga
October’s Stock Market Mojo
Via Talk Markets
This Is What Whales Are Betting On Pfizer
Via Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:PFE.
Via Chartmill
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
Via Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
Via InvestorPlace
Exposures COVID-19
2 Magnificent Growth Stocks to Buy Right Now
Via The Motley Fool
Sure Winners: 7 Stocks Set to Outperform in the Next Recession
Via InvestorPlace
Topics Economy
Exposures Economy
'Traylor' Effect? Pfizer, Campbell's Soup, Other Brands Are Basking In Travis Kelce-Taylor Swift Romance Rumors
Via Benzinga
Is Pfizer Stock a Buy Now?
Via The Motley Fool
The Latest Analyst Ratings for Pfizer
Via Benzinga
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Via Benzinga
Exposures COVID-19 Product Safety
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
Via The Motley Fool
The 3 Top Value Stocks to Watch in Q4 2023
Via InvestorPlace
3 Massively Undervalued Dividend Stocks to Buy for High Total Returns
Via InvestorPlace
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
Via InvestorPlace
3 Top Stocks to Buy in October and Hold Forever
Via The Motley Fool
Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
Via Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.